Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.00 Analyst target: $3.70 Upside: 23.13%
Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. The company is headquartered in Redwood City, California.
See the full interactive analysis & chart →Informational only — not investment advice.